42 research outputs found
Patterns of perception toward influenza pandemic among the front-line responsible health personnel in southern Thailand: a Q methodology approach
Recommended from our members
Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors
Several candidate genes have been identified in relation to lipid metabolism, and among these, lipoprotein lipase (LPL) and apolipoprotein E (APOE) gene polymorphisms are major sources of genetically determined variation in lipid concentrations. This study investigated the association of two single nucleotide polymorphisms (SNPs) at LPL, seven tagging SNPs at the APOE gene, and a common APOE haplotype (two SNPs) with blood lipids, and examined the interaction of these SNPs with dietary factors.
METHODS:
The population studied for this investigation included 660 individuals from the Prevention of Cancer by Intervention with Selenium (PRECISE) study who supplied baseline data. The findings of the PRECISE study were further replicated using 1238 individuals from the Caerphilly Prospective cohort (CaPS). Dietary intake was assessed using a validated food-frequency questionnaire (FFQ) in PRECISE and a validated semi-quantitative FFQ in the CaPS. Interaction analyses were performed by including the interaction term in the linear regression model adjusted for age, body mass index, sex and country.
RESULTS:
There was no association between dietary factors and blood lipids after Bonferroni correction and adjustment for confounding factors in either cohort. In the PRECISE study, after correction for multiple testing, there was a statistically significant association of the APOE haplotype (rs7412 and rs429358; E2, E3, and E4) and APOE tagSNP rs445925 with total cholesterol (P = 4 × 10- 4 and P = 0.003, respectively). Carriers of the E2 allele had lower total cholesterol concentration (5.54 ± 0.97 mmol/L) than those with the E3 (5.98 ± 1.05 mmol/L) (P = 0.001) and E4 (6.09 ± 1.06 mmol/L) (P = 2 × 10- 4) alleles. The association of APOE haplotype (E2, E3, and E4) and APOE SNP rs445925 with total cholesterol (P = 2 × 10- 6 and P = 3 × 10- 4, respectively) was further replicated in the CaPS. Additionally, significant association was found between APOE haplotype and APOE SNP rs445925 with low density lipoprotein cholesterol in CaPS (P = 4 × 10- 4 and P = 0.001, respectively). After Bonferroni correction, none of the cohorts showed a statistically significant SNP-diet interaction on lipid outcomes.
CONCLUSION:
In summary, our findings from the two cohorts confirm that genetic variations at the APOE locus influence plasma total cholesterol concentrations, however, the gene-diet interactions on lipids require further investigation in larger cohorts
Exploring student preferences with a Q-sort: the development of an individualized renal physiology curriculum
Habitat fragmentation and ecological traits influence the prevalence of avian blood parasites in a tropical rainforest landscape
In the tropical rainforests of northern Australia, we investigated the effects of habitat fragmentation and ecological parameters on the prevalence of blood-borne parasites (Plasmodium and Haemoproteus) in bird communities. Using mist-nets on forest edges and interiors, we sampled bird communities across six study sites: 3 large fragments (20–85 ha) and 3 continuous-forest sites. From 335 mist-net captures, we recorded 28 bird species and screened 299 bird samples with PCR to amplify and detect target DNA. Of the 28 bird species sampled, 19 were infected with Plasmodium and/or Haemoproteus and 9 species were without infection. Over one third of screened birds (99 individuals) were positive for Haemoproteus and/or Plasmodium. In forest fragments, bird capture rates were significantly higher than in continuous forests, but bird species richness did not differ. Unexpectedly, we found that the prevalence of the dominant haemosporidian infection, Haemoproteus, was significantly higher in continuous forest than in habitat fragments. Further, we found that ecological traits such as diet, foraging height, habitat specialisation and distributional ranges were significantly associated with blood-borne infections
Evaluating the neonatal BCG vaccination programme in Ireland
Background: The aim of this study was to compare the cost effectiveness of the current Irish programme of
universal BCG vaccination of infants versus a programme which considered selectively vaccinating high risk infants
using decision analytical modelling.
Methods: The efficacy of the BCG vaccine was re-evaluated to inform a decision analytical model constructed to
follow a birth cohort of vaccinated and unvaccinated infants over a 15 year time horizon. The number of life years
gained (LYG) was the primary outcome measure and this was compared to the net cost of the vaccination strategies.
Results: In the base case analysis, the incremental cost effectiveness ratios (ICERs) for the universal strategy and
selective strategy vs no vaccination were €204,373/LYG and €143,233/LYG respectively. When comparing the
incremental difference in moving from the universal to the selective strategy, the selective strategy costs
€1,055,692 less per 4.8 life years lost per birth cohort. One way sensitivity analyses highlighted that a move from
the universal to the selective strategy was particularly sensitive to the estimate of vaccine efficacy against deaths,
the cost of administering the vaccine and the multiplier used to apportion risk of contracting tuberculosis.
Probabilistic analysis suggested that a move from a universal based strategy to a selective based strategy could
be deemed cost effective (probability of cost effectiveness is 76.8 %).
Conclusion: The results of the study support the protective effect of the BCG vaccine in infants and quantified the
cost effectiveness of the current BCG vaccination strategy and the decremental difference in moving to a selective
strategy. This analysis highlights that the additional protection offered by the universal vaccination strategy is small
compared to that of the selective strategy. Consideration should therefore be given to the implementation of a
selective vaccination strategy, and diverting resources to improve TB case management and control
CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment
PURPOSE: The cytochrome P450 2C9 enzyme (CYP2C9) is involved in metabolism of endogenous compounds, drugs and procarcinogens. Two common nonsynonymous polymorphisms in CYP2C9 are associated with reduced enzyme activity: CYP2C9*2 (rs1799853, R144C) and CYP2C9*3 (rs1057910, I359L). METHODS: We investigated whether CYP2C9 genotype was associated with risk of colorectal adenoma and/or modified associations with aspirin treatment or cigarette smoking in a cohort of 928 participants in a randomized trial of aspirin chemoprevention. Generalized linear regression was used to compute relative risks (RRs) and 95% confidence intervals (95% CIs). Multiplicative interactions terms were used to assess effect modification. RESULTS: CYP2C9 genotype was associated with increased risks for adenoma recurrence of 29% (RR=1.29, 95% CI =1.09–1.51) for ≥1 variant allele (CYP2C9*2 or *3) and 47% (RR=1.47, 95% CI=1.19–1.83) for ≥1 CYP2C9*3 allele. The risk for advanced lesions or multiple (≥3) adenomas was increased by 64% (RR=1.64, 95% CI=1.18–2.28) for ≥1 variant allele (CYP2C9*2 or *3) and 79% (RR=1.79, 95% CI=1.16–2.75) for ≥1 CYP2C9*3 allele. Genotype modified associations with smoking, but not aspirin treatment. The adenoma risk was increased by 26% (RR=1.26, 95% CI=0.99–1.58) for former smokers and 60% (RR=1.60, 95% CI=1.19–2.15) for current smokers among wild-type individuals, but there was no increased risk among individuals with ≥1 variant allele (CYP2C9*2 or *3) (P(interaction)=0.04). CONCLUSIONS: Carriers of CYP2C9 variants with lower enzyme activity have increased overall risk of colorectal adenoma but reduced adenoma risk associated with cigarette smoking. These results may be due to effects on the synthesis of endogenous eicosanoids and/or reduced activation of procarcinogens in smoke by CYP2C9 variants